CASTLE BIOSCIENCES, INC. (CSTL) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 2.92M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 7.16M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | 266.81M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 561.18M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $2.92M | $7.16M | (m) | $266.81M | $561.18M | (m) |
| 2026-03-31 | (m) | (m) | $1.67M | $8.40M | (m) | $261.69M | $547.80M | (m) |
| 2025-12-31 | (m) | (m) | $417.00K | $9.64M | (m) | $299.50M | $578.56M | (m) |
| 2025-09-30 | (m) | (m) | $0.00 | $10.05M | (m) | $287.54M | $562.79M | (m) |
| 2025-06-30 | (m) | (m) | $1.94M | $8.10M | (m) | $275.93M | $544.73M | (m) |
| 2025-03-31 | (m) | (m) | $1.11M | $8.92M | (m) | $275.15M | $501.71M | (m) |
| 2024-12-31 | (m) | (m) | $278.00K | $9.74M | (m) | $293.13M | $531.24M | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | $10.02M | (m) | $279.79M | $514.57M | (m) |
| 2024-06-30 | (m) | (m) | $0.00 | $10.01M | (m) | $259.69M | $487.31M | (m) |
| 2024-03-31 | (m) | (m) | $0.00 | $10.00M | (m) | $239.21M | $458.51M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $0.00 | (m) | $243.10M | $453.34M | (m) |
| 2020-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $439.33M | (m) |
| 2020-09-30 | (m) | (m) | $10.00M | $12.46M | (m) | (m) | $210.39M | (m) |
| 2020-06-30 | (m) | (m) | $10.00M | $14.74M | (m) | (m) | $201.55M | (m) |
| 2020-03-31 | (m) | (m) | $8.33M | $17.01M | (m) | (m) | $120.26M | (m) |
| 2019-12-31 | (m) | (m) | $5.83M | $19.29M | (m) | (m) | $119.75M | (m) |
| 2019-09-30 | (m) | (m) | $3.33M | $21.57M | (m) | (m) | $113.20M | (m) |
| 2019-06-30 | (m) | (m) | $833.33K | $23.86M | (m) | (m) | $33.35M | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | $24.50M | (m) | (m) | $22.40M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |